Scientists investigate this peptide across numerous research models involving connective tissue, muscle recovery, gastrointestinal biology, wound healing, and inflammatory regulation
The fundamental distinction lies in the mechanism of action: GLP-1 agonists are receptor-specific molecules that directly stimulate GLP-1 receptors, while berberine exerts its metabolic effects primarily through AMPK activation and other pathways that do not involve direct GLP-1 receptor engagement
Originally investigated as a potential treatment for Alzheimers disease, Dihexa demonstrates potent ability to enhance synaptic connections and promote neuronal survival through modulation of hepatocyte growth factor (HGF) and its receptor c-Met, which play crucial roles in brain development and neuronal health
Thats why personalized support is essential
A 2021 randomized controlled trial did find increased GLP-1 activity in subjects taking berberine, but could not determine if berberine caused the effect directly or indirectly